Mara G. Aspinall - 23 May 2024 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2024, 18:52:17 UTC
Prior SEC filing
16 May 2024
Next SEC filing
15 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Frank Stokes, Attorney-in-fact

Key filing fact

Mara G. Aspinall filed Form 4 for CASTLE BIOSCIENCES INC (CSTL) on 04 Jun 2024.

Key facts

  • This page summarizes Mara G. Aspinall's Form 4 filing for CASTLE BIOSCIENCES INC (CSTL).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Jun 2024, 18:52.

Change

  • Previous filing in this sequence was filed on 16 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSTL transaction

Common Stock

Options Exercise

Transaction value
Shares
+8,636
Change %
+24%
Price
Shares after
44,139
Date
23 May 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSTL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-8,636
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,636
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mara G. Aspinall is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Footnote F2

Each consists of a grant of restricted stock units awarded to the Reporting Person on May 25th, 2023 under the "Non Employee Director Compensation Policy". Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Subject to the Reporting Person's continuous service with the Issuer, shares will be issuable to the Reporting Person upon the settlement of the restricted stock unit award, which vests in full on the earlier of (a) the one-year anniversary of the date of grant and (b) the day immediately preceding the next Annual Meeting of Stockholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .